Kush Parmar sold Entrada Therapeutics ($TRDA) shares on the open market nine times over the past year, totaling $2.83 million, with the latest sale on November 14, 2025. These sales rank 2,827th among 11,678 insiders in our database, below the average of $8.59 million per seller and 6.37 transactions. Parmar made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 14, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 200000 | $8.80 | 4,056,379.0000 | 41,462,567 | 4.70% | 0.48% |
| July 9, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 6935 | $7.50 | 4,256,379.0000 | 39,003,169 | 0.16% | 0.02% |
| July 9, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 20065 | $7.50 | 4,256,379.0000 | 39,003,169 | 0.47% | 0.05% |
| June 30, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 18578 | $6.81 | 4,301,957.0000 | 39,003,169 | 0.43% | 0.05% |
| June 27, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 55735 | $6.91 | 4,320,535.0000 | 39,003,169 | 1.27% | 0.14% |
| June 27, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 19265 | $6.91 | 4,296,223.0000 | 39,003,169 | 0.45% | 0.05% |
| June 30, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 6422 | $6.81 | 4,289,801.0000 | 39,003,169 | 0.15% | 0.02% |
| July 1, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 18578 | $7.12 | 4,283,379.0000 | 39,003,169 | 0.43% | 0.05% |
| July 1, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Not found | S | Common Stock | 6422 | $7.12 | 4,283,379.0000 | 39,003,169 | 0.15% | 0.02% |
| June 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Director | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 39,003,169 | 9999.99% | 0.05% |
| June 13, 2024 | Entrada Therapeutics, Inc. | $TRDA | PARMAR KUSH | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 33,050,319 | 9999.99% | 0.05% |
| May 15, 2024 | Rallybio Corp | $RLYB | PARMAR KUSH | Director | A | Option (Right to Buy) | 16500 | $0.00 | 16,500.0000 | 40,447,388 | 9999.99% | 0.04% |
| Jan. 2, 2024 | Rallybio Corp | $RLYB | PARMAR KUSH | Director | A | Option (Right to Buy) | 27118 | $1.77 | 27,118.0000 | 40,447,388 | 9999.99% | 0.07% |